U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06926946) titled 'SafeBoosC-IIIv - Does Cerebral Oximetry Monitoring Affect Renal Outcomes' on April 02.
Brief Summary: Cerebral oximetry monitoring allows clinicians to optimize blood flow to the brain and oxygenation using the SafeBoosC treatment guideline. The guideline's interventions aims to stabilize blood pressure and oxygen levels.
As low blood pressure is a risk factor for the development of kidney injury, normalizing blood pressure may decrease the incidence of kidney injury in new-borns who are on ventilator.
Study Start Date: May 29
Study Type: INTERVENTIONAL
Condition:
Acute Renal Failure
Neonatal Morbidity
Intervention:
OTHER: I...